EYPT Competitors & Alternatives
Compare Eyepoint Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
EYPT
Main Stock$14.38
Tradestie Score
58
Market Cap
$890.20M
Revenue Growth
1.6%
Analyst Upside
+157.3%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PGEN
Precigen, Inc. Common Stock
|
$5.36
|
$1.18B | - | 59 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$48.60
|
$1.17B | - | 57 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$23.55
|
$1.15B | 3.6 | 67 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$17.38
|
$1.14B | - | 57 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$8.91
|
$1.14B | - | 61 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$26.41
|
$1.13B | - | 58 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$6.04
|
$1.12B | - | 59 | Compare |
|
NKTR
Nektar Therapeutics
|
$66.69
|
$1.12B | - | 51 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$305.37
|
$1.12B | - | 59 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.91
|
$1.09B | - | 57 | Compare |
More EYPT Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 3826)
226 stocks in this industry